111 related articles for article (PubMed ID: 10422817)
21. Sarcomatoid renal cell carcinoma. A study of its proliferative activity.
Oda H; Machinami R
Cancer; 1993 Apr; 71(7):2292-8. PubMed ID: 8095849
[TBL] [Abstract][Full Text] [Related]
22. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma.
Palazzo JP; Kafka NJ; Grasso L; Chakrani F; Hanau C; Cuesta KH; Mercer WE
Hum Pathol; 1997 Oct; 28(10):1189-95. PubMed ID: 9343326
[TBL] [Abstract][Full Text] [Related]
23. [Non-metastatic clear cell renal carcinoma: prognostic significance of morphometric and biomolecular factors].
Iurin AG
Vopr Onkol; 2009; 55(2):177-82. PubMed ID: 19514371
[TBL] [Abstract][Full Text] [Related]
24. Expression of bcl-2 oncoprotein in renal cell tumours.
Paraf F; Gogusev J; Chrétien Y; Droz D
J Pathol; 1995 Nov; 177(3):247-52. PubMed ID: 8551386
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of the immunohistochemical aspects of tumor suppressor genes p53, bcl-2, PTEN and nuclear proliferative antigen Ki-67 in resected colorectal carcinoma.
Ghiţă C; Vîlcea ID; Dumitrescu M; Vîlcea AM; Mirea CS; Aşchie M; Vasilescu F
Rom J Morphol Embryol; 2012; 53(3):549-56. PubMed ID: 22990545
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
[TBL] [Abstract][Full Text] [Related]
28. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma.
Zhang X; Takenaka I
Urology; 2000 Sep; 56(3):510-5. PubMed ID: 10962335
[TBL] [Abstract][Full Text] [Related]
29. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
30. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
33. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
34. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.
Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M
Anticancer Res; 1998; 18(1B):615-8. PubMed ID: 9568186
[TBL] [Abstract][Full Text] [Related]
35. P53, bcl-2, and Bax expression in renal cell carcinoma.
Vasavada SP; Novick AC; Williams BR
Urology; 1998 Jun; 51(6):1057-61. PubMed ID: 9609655
[TBL] [Abstract][Full Text] [Related]
36. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia.
Mahomed A; Chetty R
Arch Ophthalmol; 2002 May; 120(5):554-8. PubMed ID: 12003603
[TBL] [Abstract][Full Text] [Related]
39. Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases.
Harada K; Sakai I; Ishimura T; Inoue TA; Hara I; Miyake H
Urol Oncol; 2006; 24(3):201-6. PubMed ID: 16678049
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
